178 related articles for article (PubMed ID: 30473433)
1. Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer.
Lam TBL; MacLennan S; Plass K; Willemse PM; Mason MD; Cornford P; Donaldson J; Davis NF; Dell'Oglio P; Fankhauser C; Grivas N; Ingels A; Lardas M; Liew M; Pang KH; Paterson C; Omar MI; Zattoni F; Buddingh KT; Van den Broeck T; Cumberbatch MG; Fossati N; Gross T; Moris L; Schoots IG; van den Bergh RCN; Briers E; Fanti S; De Santis M; Gillessen S; Grummet JP; Henry AM; van der Poel HG; van der Kwast TH; Rouvière O; Tilki D; Wiegel T; N'Dow J; Van Poppel H; Mottet N
Eur Urol; 2019 Apr; 75(4):699-702. PubMed ID: 30473433
[No Abstract] [Full Text] [Related]
2. EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study).
Lam TBL; MacLennan S; Willemse PM; Mason MD; Plass K; Shepherd R; Baanders R; Bangma CH; Bjartell A; Bossi A; Briers E; Briganti A; Buddingh KT; Catto JWF; Colecchia M; Cox BW; Cumberbatch MG; Davies J; Davis NF; De Santis M; Dell'Oglio P; Deschamps A; Donaldson JF; Egawa S; Fankhauser CD; Fanti S; Fossati N; Gandaglia G; Gillessen S; Grivas N; Gross T; Grummet JP; Henry AM; Ingels A; Irani J; Lardas M; Liew M; Lin DW; Moris L; Omar MI; Pang KH; Paterson CC; Renard-Penna R; Ribal MJ; Roobol MJ; Rouprêt M; Rouvière O; Sancho Pardo G; Richenberg J; Schoots IG; Sedelaar JPM; Stricker P; Tilki D; Vahr Lauridsen S; van den Bergh RCN; Van den Broeck T; van der Kwast TH; van der Poel HG; van Leenders GJLH; Varma M; Violette PD; Wallis CJD; Wiegel T; Wilkinson K; Zattoni F; N'Dow JMO; Van Poppel H; Cornford P; Mottet N
Eur Urol; 2019 Dec; 76(6):790-813. PubMed ID: 31587989
[TBL] [Abstract][Full Text] [Related]
3. EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
Horwich A; Babjuk M; Bellmunt J; Bruins HM; De Reijke TM; De Santis M; Gillessen S; James N; Maclennan S; Palou J; Powles T; Ribal MJ; Shariat SF; Van Der Kwast T; Xylinas E; Agarwal N; Arends T; Bamias A; Birtle A; Black PC; Bochner BH; Bolla M; Boormans JL; Bossi A; Briganti A; Brummelhuis I; Burger M; Castellano D; Cathomas R; Chiti A; Choudhury A; Compérat E; Crabb S; Culine S; De Bari B; DeBlok W; De Visschere PJL; Decaestecker K; Dimitropoulos K; Dominguez-Escrig JL; Fanti S; Fonteyne V; Frydenberg M; Futterer JJ; Gakis G; Geavlete B; Gontero P; Grubmüller B; Hafeez S; Hansel DE; Hartmann A; Hayne D; Henry AM; Hernandez V; Herr H; Herrmann K; Hoskin P; Huguet J; Jereczek-Fossa BA; Jones R; Kamat AM; Khoo V; Kiltie AE; Krege S; Ladoire S; Lara PC; Leliveld A; Linares-Espinós E; Løgager V; Lorch A; Loriot Y; Meijer R; Carmen Mir M; Moschini M; Mostafid H; Müller AC; Müller CR; N'Dow J; Necchi A; Neuzillet Y; Oddens JR; Oldenburg J; Osanto S; Oyen WJG; Pacheco-Figueiredo L; Pappot H; Patel MI; Pieters BR; Plass K; Remzi M; Retz M; Richenberg J; Rink M; Roghmann F; Rosenberg JE; Rouprêt M; Rouvière O; Salembier C; Salminen A; Sargos P; Sengupta S; Sherif A; Smeenk RJ; Smits A; Stenzl A; Thalmann GN; Tombal B; Turkbey B; Vahr Lauridsen S; Valdagni R; Van Der Heijden AG; Van Poppel H; Vartolomei MD; Veskimäe E; Vilaseca A; Vives Rivera FA; Wiegel T; Wiklund P; Williams A; Zigeuner R; Witjes JA
Ann Oncol; 2019 Nov; 30(11):1697-1727. PubMed ID: 31740927
[TBL] [Abstract][Full Text] [Related]
4. Advanced Prostate Cancer: AUA/ASTRO/SUO Guideline PART I.
Lowrance WT; Breau RH; Chou R; Chapin BF; Crispino T; Dreicer R; Jarrard DF; Kibel AS; Morgan TM; Morgans AK; Oh WK; Resnick MJ; Zietman AL; Cookson MS
J Urol; 2021 Jan; 205(1):14-21. PubMed ID: 32960679
[TBL] [Abstract][Full Text] [Related]
5. Eight Endorsements of the International Society of Urological Pathology from the 2019 Consensus Conference on Grading of Prostatic Carcinoma.
Iczkowski KA; van Leenders GJLH
J Urol; 2021 Jan; 205(1):8-10. PubMed ID: 32897768
[No Abstract] [Full Text] [Related]
6. Experts Develop New Guideline for Advanced Prostate Cancer.
Broderick JM
Oncology (Williston Park); 2020 Aug; 34(8):305-306. PubMed ID: 32785924
[TBL] [Abstract][Full Text] [Related]
7. Editorial comment.
Shore ND
Urology; 2011 May; 77(5):1095; author reply 1095-6. PubMed ID: 21539959
[No Abstract] [Full Text] [Related]
8. Effect of urologists and medical oncologists on treatment of elderly men with Stage IV prostate cancer.
Onukwugha E; Mullins CD; Hsu VD; Seal B; Hussain A
Urology; 2011 May; 77(5):1088-95. PubMed ID: 21439617
[TBL] [Abstract][Full Text] [Related]
9. [Combined chemohormonal therapy for metastatic hormone-sensitive prostate cancer : Effectiveness and update as a joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)].
Ohlmann CH; Gschwend J; Miller K;
Urologe A; 2015 Nov; 54(11):1606-8. PubMed ID: 26385244
[No Abstract] [Full Text] [Related]
10. [Searching for clues].
Steffens JA
Urologe A; 2010 Aug; 49(8):907-9. PubMed ID: 20652678
[No Abstract] [Full Text] [Related]
11. [Specialist uro-oncological rehabilitation after treatment for prostate cancer--update 2015. Position statement of the working group on "rehabilitation of urological and nephrological diseases" of the German Society of Urology with respect to current S3 guidelines].
Müller G; Otto U; Vahlensieck W; Zermann DH
Urologe A; 2015 Aug; 54(8):1108-14. PubMed ID: 26246209
[TBL] [Abstract][Full Text] [Related]
12. Active Surveillance: Very Much "Preferred" for Low-Risk Prostate Cancer.
Cooperberg MR; Lin DW; Morgan TM; Chapin BF; Chen RC; Eggener SE
J Urol; 2022 Feb; 207(2):262-264. PubMed ID: 34775795
[No Abstract] [Full Text] [Related]
13. [Diagnosis, prognosis and treatment of low-risk prostate cancer - Expert panel from the 2015 BPS Annual Meeting].
Dietz J
Urologe A; 2016 Jun; 55(6):823-4. PubMed ID: 27165033
[No Abstract] [Full Text] [Related]
14. ["Expanded prostate cancer index composite" (EPIC-26): Results of functional treatment in patients with localized prostate cancer].
Beyer B; Huland H; Feick G; Graefen M
Urologe A; 2015 Nov; 54(11):1591-5. PubMed ID: 26347350
[TBL] [Abstract][Full Text] [Related]
15. Management of Prostate Cancer in Elderly Patients: Recommendations of a Task Force of the International Society of Geriatric Oncology.
Droz JP; Albrand G; Gillessen S; Hughes S; Mottet N; Oudard S; Payne H; Puts M; Zulian G; Balducci L; Aapro M
Eur Urol; 2017 Oct; 72(4):521-531. PubMed ID: 28089304
[TBL] [Abstract][Full Text] [Related]
16. [Quality in urology].
Miller K
Urologe A; 2016 Sep; 55(9):1163. PubMed ID: 27514388
[No Abstract] [Full Text] [Related]
17. Consensus statements on the management of metastatic prostate cancer from the Hong Kong Urological Association and Hong Kong Society of Uro-Oncology.
Poon DM; Chan CK; Chan TW; Cheung FY; Kwong PW; Lee EK; Leung AK; Leung SY; Ma WK; So HS; Tam PC; Ho LY
BJU Int; 2018 May; 121(5):703-715. PubMed ID: 29211320
[TBL] [Abstract][Full Text] [Related]
18. Urologic cancer research at the National Cancer Institute.
Chiarodo A
Semin Urol; 1993 Feb; 11(1):2-6. PubMed ID: 8465123
[No Abstract] [Full Text] [Related]
19. [Androgen deprivation plus abiraterone/prednisone in metastatic hormone-sensitive prostate cancer : Joint statement by the Study Group on Oncology (AKO) and the Working Group on Urological Oncology (AUO)].
Ohlmann CH; Miller K; Gschwend J
Urologe A; 2017 Sep; 56(9):1185-1186. PubMed ID: 28733874
[No Abstract] [Full Text] [Related]
20. [Methodology and process of developing the S3 guideline for prostate cancer].
Nothacker M; Röllig C; Wöckel A; Kopp I; Ollenschläger G; Weinbrenner S
Urologe A; 2010 Feb; 49(2):173-80. PubMed ID: 20180056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
